other material
confidence high
sentiment neutral
materiality 0.35
Cadrenal Therapeutics files prospectus supplement for up to $1.77M ATM offering
Cadrenal Therapeutics, Inc.
- Already sold $10,005,300 in shares under the existing ATM agreement since March 2024.
- New tranche of up to $1,770,028 of common stock through H.C. Wainwright as sales agent.
- Commission of 3.0% of gross proceeds payable to Wainwright for its services.
- Offer made under existing effective S-3 registration statement filed March 2024.